227 related articles for article (PubMed ID: 36217030)
1. A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets.
Zhou Y; Liu Y; Gupta S; Paramo MI; Hou Y; Mao C; Luo Y; Judd J; Wierbowski S; Bertolotti M; Nerkar M; Jehi L; Drayman N; Nicolaescu V; Gula H; Tay S; Randall G; Wang P; Lis JT; Feschotte C; Erzurum SC; Cheng F; Yu H
Nat Biotechnol; 2023 Jan; 41(1):128-139. PubMed ID: 36217030
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive SARS-CoV-2-human protein-protein interactome network identifies pathobiology and host-targeting therapies for COVID-19.
Zhou Y; Liu Y; Gupta S; Paramo MI; Hou Y; Mao C; Luo Y; Judd J; Wierbowski S; Bertolotti M; Nerkar M; Jehi L; Drayman N; Nicolaescu V; Gula H; Tay S; Randall G; Lis JT; Feschotte C; Erzurum SC; Cheng F; Yu H
Res Sq; 2022 Jun; ():. PubMed ID: 35677070
[TBL] [Abstract][Full Text] [Related]
3. Mapping the SARS-CoV-2-Host Protein-Protein Interactome by Affinity Purification Mass Spectrometry and Proximity-Dependent Biotin Labeling: A Rational and Straightforward Route to Discover Host-Directed Anti-SARS-CoV-2 Therapeutics.
Terracciano R; Preianò M; Fregola A; Pelaia C; Montalcini T; Savino R
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430309
[TBL] [Abstract][Full Text] [Related]
4. COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection.
Messina F; Giombini E; Agrati C; Vairo F; Ascoli Bartoli T; Al Moghazi S; Piacentini M; Locatelli F; Kobinger G; Maeurer M; Zumla A; Capobianchi MR; Lauria FN; Ippolito G;
J Transl Med; 2020 Jun; 18(1):233. PubMed ID: 32522207
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of dynamic transcriptomes reveals specific COVID-19 features and pathogenesis of immunocompromised populations.
Yang X; Zhu J; Wang Q; Tang B; Shen Y; Wang B; Ji L; Liu H; Wuchty S; Zhang Z; Dong Y; Liang Z
mSystems; 2024 Jun; 9(6):e0138523. PubMed ID: 38752789
[TBL] [Abstract][Full Text] [Related]
6. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
Gordon DE; Jang GM; Bouhaddou M; Xu J; Obernier K; White KM; O'Meara MJ; Rezelj VV; Guo JZ; Swaney DL; Tummino TA; Hüttenhain R; Kaake RM; Richards AL; Tutuncuoglu B; Foussard H; Batra J; Haas K; Modak M; Kim M; Haas P; Polacco BJ; Braberg H; Fabius JM; Eckhardt M; Soucheray M; Bennett MJ; Cakir M; McGregor MJ; Li Q; Meyer B; Roesch F; Vallet T; Mac Kain A; Miorin L; Moreno E; Naing ZZC; Zhou Y; Peng S; Shi Y; Zhang Z; Shen W; Kirby IT; Melnyk JE; Chorba JS; Lou K; Dai SA; Barrio-Hernandez I; Memon D; Hernandez-Armenta C; Lyu J; Mathy CJP; Perica T; Pilla KB; Ganesan SJ; Saltzberg DJ; Rakesh R; Liu X; Rosenthal SB; Calviello L; Venkataramanan S; Liboy-Lugo J; Lin Y; Huang XP; Liu Y; Wankowicz SA; Bohn M; Safari M; Ugur FS; Koh C; Savar NS; Tran QD; Shengjuler D; Fletcher SJ; O'Neal MC; Cai Y; Chang JCJ; Broadhurst DJ; Klippsten S; Sharp PP; Wenzell NA; Kuzuoglu-Ozturk D; Wang HY; Trenker R; Young JM; Cavero DA; Hiatt J; Roth TL; Rathore U; Subramanian A; Noack J; Hubert M; Stroud RM; Frankel AD; Rosenberg OS; Verba KA; Agard DA; Ott M; Emerman M; Jura N; von Zastrow M; Verdin E; Ashworth A; Schwartz O; d'Enfert C; Mukherjee S; Jacobson M; Malik HS; Fujimori DG; Ideker T; Craik CS; Floor SN; Fraser JS; Gross JD; Sali A; Roth BL; Ruggero D; Taunton J; Kortemme T; Beltrao P; Vignuzzi M; García-Sastre A; Shokat KM; Shoichet BK; Krogan NJ
Nature; 2020 Jul; 583(7816):459-468. PubMed ID: 32353859
[TBL] [Abstract][Full Text] [Related]
7. Integrated interactome and transcriptome analysis reveals key host factors critical for SARS-CoV-2 infection.
Sheng J; Li L; Lv X; Gao M; Chen Z; Zhou Z; Wang J; Wu A; Jiang T
Virol Sin; 2023 Aug; 38(4):508-519. PubMed ID: 37169126
[TBL] [Abstract][Full Text] [Related]
8. High-sensitivity profiling of SARS-CoV-2 noncoding region-host protein interactome reveals the potential regulatory role of negative-sense viral RNA.
Jiang L; Xiao M; Liao QQ; Zheng L; Li C; Liu Y; Yang B; Ren A; Jiang C; Feng XH
mSystems; 2023 Aug; 8(4):e0013523. PubMed ID: 37314180
[TBL] [Abstract][Full Text] [Related]
9. A New Cellular Interactome of SARS-CoV-2 Nucleocapsid Protein and Its Biological Implications.
Min YQ; Huang M; Feng K; Jia Y; Sun X; Ning YJ
Mol Cell Proteomics; 2023 Jul; 22(7):100579. PubMed ID: 37211047
[TBL] [Abstract][Full Text] [Related]
10. Super-resolution proximity labeling reveals anti-viral protein network and its structural changes against SARS-CoV-2 viral proteins.
Lee YB; Jung M; Kim J; Charles A; Christ W; Kang J; Kang MG; Kwak C; Klingström J; Smed-Sörensen A; Kim JS; Mun JY; Rhee HW
Cell Rep; 2023 Aug; 42(8):112835. PubMed ID: 37478010
[TBL] [Abstract][Full Text] [Related]
11. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
Front Immunol; 2021; 12():789317. PubMed ID: 34975885
[TBL] [Abstract][Full Text] [Related]
12. Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome.
Messina F; Giombini E; Montaldo C; Sharma AA; Zoccoli A; Sekaly RP; Locatelli F; Zumla A; Maeurer M; Capobianchi MR; Lauria FN; Ippolito G
Cell Death Dis; 2021 Aug; 12(8):788. PubMed ID: 34385425
[TBL] [Abstract][Full Text] [Related]
13. Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism.
Policard M; Jain S; Rego S; Dakshanamurthy S
Virus Res; 2021 Aug; 301():198464. PubMed ID: 34058265
[TBL] [Abstract][Full Text] [Related]
14. Genome-Wide Characterization of SARS-CoV-2 Cytopathogenic Proteins in the Search of Antiviral Targets.
Zhang J; Li Q; Cruz Cosme RS; Gerzanich V; Tang Q; Simard JM; Zhao RY
mBio; 2021 Feb; 13(1):e0016922. PubMed ID: 35164548
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2-host proteome interactions for antiviral drug discovery.
Liu X; Huuskonen S; Laitinen T; Redchuk T; Bogacheva M; Salokas K; Pöhner I; Öhman T; Tonduru AK; Hassinen A; Gawriyski L; Keskitalo S; Vartiainen MK; Pietiäinen V; Poso A; Varjosalo M
Mol Syst Biol; 2021 Nov; 17(11):e10396. PubMed ID: 34709727
[TBL] [Abstract][Full Text] [Related]
16. The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.
Marchi R; Sugita B; Centa A; Fonseca AS; Bortoletto S; Fiorentin K; Ferreira S; Cavalli LR
Infect Genet Evol; 2021 Jul; 91():104832. PubMed ID: 33812037
[TBL] [Abstract][Full Text] [Related]
17. Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing.
Das AB
BMC Med Genomics; 2021 Sep; 14(1):226. PubMed ID: 34535131
[TBL] [Abstract][Full Text] [Related]
18. Discovery of host-directed modulators of virus infection by probing the SARS-CoV-2-host protein-protein interaction network.
Ravindran V; Wagoner J; Athanasiadis P; Den Hartigh AB; Sidorova JM; Ianevski A; Fink SL; Frigessi A; White J; Polyak SJ; Aittokallio T
Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36305426
[TBL] [Abstract][Full Text] [Related]
19. Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses.
Tushir S; Kamanna S; Nath SS; Bhat A; Rose S; Aithal AR; Tatu U
J Proteome Res; 2021 Mar; 20(3):1591-1601. PubMed ID: 33555895
[TBL] [Abstract][Full Text] [Related]
20. A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection.
Ahmed F
Front Immunol; 2020; 11():590459. PubMed ID: 33362771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
